Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.42 From HK$6.16, Keeps at Buy
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.42 From HK$6.16, Keeps at Buy
野村將S Bpharm B2502的目標價從HK＄6.16調整爲HK＄6.42，並保持買入。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間